What Is Fibromyalgia?

Fibromyalgia is a chronic syndrome characterized by widespread musculoskeletal pain that occurs without detectable tissue damage or inflammation sufficient to explain its severity.

It is ranked as the third most prevalent musculoskeletal condition globally, affecting an estimated 2–3% of the world's population. The pain is diffuse — often described as deep aching, burning, or gnawing that shifts across muscles, tendons, and ligaments.

Core Symptoms

  • Widespread pain — lasting at least 3 months, affecting multiple body regions
  • Fatigue — not resolved by rest, often overwhelming
  • Sleep disturbances — unrefreshing sleep, disrupted architecture
  • Cognitive difficulties — memory problems, impaired concentration, "fibro fog"
  • Sensory sensitivity — hyperalgesia (heightened pain) and allodynia (pain from normally non-painful stimuli)

A Real Condition, Not "All in Your Head"

The ICD-11 classifies fibromyalgia as "chronic primary widespread pain" (MG30.01). The IASP introduced nociplastic pain in 2017 specifically for conditions like fibromyalgia — pain arising from altered nociception in the central nervous system, without clear tissue damage.

Research using brain imaging consistently shows hyperactivity in the anterior insula and anterior cingulate cortex — the brain regions responsible for processing pain signals. This is not imagination. This is neuroscience.

Who Is Affected?

Fibromyalgia affects women approximately 3–4 times more often than men. It typically emerges between ages 30–35 and peaks in prevalence at 50–60 years. However, it can occur at any age, including adolescence.

Importantly, men are systematically underdiagnosed. Under the old 1990 criteria (tender points), the female-to-male ratio was 13.7:1. Under the 2010 revised criteria, it dropped to 4.8:1 — suggesting many men were missed because their symptom presentation differed.

The Economic Burden

A Danish cohort study of 9,712 patients revealed devastating impacts:

  • Only 25.5% employed at time of diagnosis (vs. 64.8% of general population)
  • Income declining for 5+ years before diagnosis
  • 50% received disability pensions within 10 years of diagnosis
  • €27,193 average annual societal cost per patient (77% indirect costs)

Your pain is real. The science is advancing. And you are not alone in this journey.